CellCentric

CellCentric is a clinical-stage biotech company focused on developing novel cancer treatments. The company is pioneering the use of p300/CBP inhibitors, specifically inobrodib, to target specific cancer types, most notably relapsed refractory multiple myeloma. Inobrodib is a first-in-class oral drug with a unique mechanism of action, targeting the conserved bromodomain of the p300/CBP proteins. This leads to the inhibition of key cancer driver genes like MYC and IRF4, impacting the growth and progression of tumors.

CellCentric's mission is to transform cancer treatment outcomes for patients by developing inobrodib as quickly and effectively as possible. They have built a strong network of research collaborators, engage with patient representative groups, and are currently conducting Phase II clinical trials in the UK, US, and Europe. The company is committed to finding new and innovative ways to treat cancer and improve the lives of people living with the disease.

CellCentric offers the flexibility of working from home as their drug, Inobrodib, is oral and can be taken at home. While no explicit mention of remote work is made in the job postings, this suggests the company is open to flexible arrangements for those who need them.

CellCentric is a clinical-stage biotech company dedicated to improving outcomes for patients with specific cancers, particularly relapsed refractory multiple myeloma. They aim to achieve this by developing inobrodib, a first-in-class oral p300/CBP inhibitor drug, as quickly and effectively as possible. Their mission is driven by a strong commitment to scientific innovation and patient-centric care, fostering collaborations with leading research centers and engaging with patient communities to ensure their needs and priorities are understood and addressed.

CellCentric cultivates a collaborative and supportive culture, prioritizing open communication, inquisitiveness, and shared goals. Their diverse, complementary, and motivated team thrives on a dynamic environment that fosters innovation and a collective drive to improve the lives of cancer patients.

CellCentric values a diverse, complementary, and motivated team, believing that an open, inquisitive, and supportive culture fosters success. They actively work to create an inclusive environment that embraces a range of perspectives and experiences, driving towards their shared goal of improving the lives of people with cancer. Their team reflects a variety of backgrounds and expertise, demonstrating their commitment to a diverse and equitable workplace.